resveratrol has been researched along with gsk2879552 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, LN; Duan, YC; Guan, YY; Liu, HM; Liu, XQ; Qin, WP; Shen, DD; Sun, XD; Zhai, XY; Zheng, YC | 1 |
| Agboyibor, C; Bi, Y; Dong, J; Gong, H; Kang, L; Li, D; Li, J; Liu, H; Ma, X; Pervaiz, W; Tayyab, B; Zhang, H | 1 |
1 review(s) available for resveratrol and gsk2879552
| Article | Year |
|---|---|
A comprehensive comparative study on LSD1 in different cancers and tumor specific LSD1 inhibitors.
Topics: Carcinogenesis; Histone Demethylases; Humans; Neoplasms | 2022 |
1 other study(ies) available for resveratrol and gsk2879552
| Article | Year |
|---|---|
Discovery of resveratrol derivatives as novel LSD1 inhibitors: Design, synthesis and their biological evaluation.
Topics: Cell Line, Tumor; Chemistry Techniques, Synthetic; Drug Design; Enzyme Inhibitors; Histone Demethylases; Humans; Molecular Docking Simulation; Protein Conformation; Resveratrol; Stilbenes | 2017 |